Questcor Pharmaceuticals (QCOR) Inactive 10-Q2008 Q1 Quarterly report

Filed: 14 May 08, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: absence, Academy, afflicted, aimed, amended, amendment, American, analogy, ARB, arrangement, assessing, assessment, attributable, authoritative, authorized, back, bargain, BioVectra, calendar, child, closing, combination, combined, commitment, comparison, conduct, conducted, consideration, constant, Consumer, contract, coverage, created, creation, cumulative, dcl, decision, deconsolidated, deconsolidation, defined, disposition, distinct, Earlier, efficacy, employment, entity, ESPP, extraction, face, FAS, feasible, flare, flexibility, FSP, GAAP, gathering, holder, Icon, identifiable, Index, industry, inflation, Issuer, IV, joint, jointly, leading, likelihood, literature, LLC, location, margin, maximum, monthly, NASDAQ, nature, negotiated, nominal, noncontrolling, observed, offering, ongoing, parent, permanently, practice, prohibited, provision, prudent, publicly, published, QCOR, qualitative, quantitative, quoted, randomized, range, rational, regularly, remove, repurchase, repurchased, resubmission, resubmit, scope, seasonal, seasonality, segment, shareholder, slightly, Society, standard, stayed, structure, successfully, support, swallowing, switch, symbol, tabulated, taxable, temporary, tolerate, transaction, trial, twelve, unchanged, variability, variation, venture, virtual

Removed: accrued, activity, adoptedFinancial, agent, approach, approximate, audit, Code, commenced, direct, establishment, examination, expand, fifteen, forward, framework, hedge, history, implementing, inception, intended, largest, license, litigation, measurement, measuring, mitigate, objective, opportunity, placement, pronouncement, recognizing, redeem, remain, reserved, resolution, settlement, step, strategic, substantial, sustained, traditional, ultimate, uncertain, unrecognized, weight

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

QCOR similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32

Certification

On May 14, 2008, Questcor Pharmaceuticals, Inc. filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2008 (the “Form 10-Q”) with the Securities and Exchange Commission. Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned hereby certify, to such persons’ knowledge, that:

(i) the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2008 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated: May 14, 2008	/s/ Don M. Bailey
	Don M. Bailey
	Chief Executive Officer



	/s/ George Stuart
	George Stuart
	Chief Financial Officer

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. § 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.